...
首页> 外文期刊>GE Portuguese journal of gastroenterology. >Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
【24h】

Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge

机译:医院出院时质子泵抑制剂的处方模式

获取原文
           

摘要

Background: Proton pump inhibitors (PPI) have reportedly been used in inappropriate clinical settings, often leading to an increased risk of adverse effects, drug interactions, and costs. Aim: The aim of this study was to evaluate the adequacy of PPI prescription in an internal medicine ward. Methods: The discharged home inpatients of a segment in the medicine department of a central hospital in the first trimester of 2017 were evaluated; those who died or were transferred to another unit were excluded. Data on gender, age, admission, and discharge therapy and diagnoses which could support PPI use were collected from clinical records. Statistical analysis was performed using Microsoft Excel 2013? and IBM SPSS Statistics 20?. Results: A total of 318 hospitalizations were included, corresponding to 301 patients; 171 (56.8%) were female and the average age was 75.4 ± 14.6 years. Among the 318 hospitalizations, 148 patients (46.5%) were on PPI at admission and 175 (55%) at discharge, the majority of them without indication ( n = 91, 61.5% vs. n = 109, 62.3%). The main inappropriate indication was anticoagulation alone ( n = 33, 36.3% vs. n = 43, 39.4%). There was indication for PPI therapy in 93 (29.2%) of the cases at admission and 111 (34.9%) at discharge, mostly for prophylaxis of gastrointestinal bleeding in high-risk patients ( n = 82, 88.2% vs. n = 96, 86.5%). Among those with indication, 57 (61.3%) were medicated at admission versus 66 (59%) at discharge. The association between PPI therapy and an indication for its prescription was lost by the time of discharge ( p = 0.245). Conclusions: PPI prescription is not in agreement with existing recommendations, which is why it should be revised at hospital discharge. The primary indication for PPI therapy is the prophylaxis of gastrointestinal bleeding in high-risk patients and the main inappropriate indication is prophylaxis in low-risk patients. A large proportion of the patients indicated for PPI use were discharged without prescription.
机译:背景:据报道,质子泵抑制剂(PPI)已在不适当的临床环境中使用,经常导致不良反应,药物相互作用和成本增加的风险。目的:本研究的目的是评估内科病房中PPI处方的适当性。方法:对2017年上半年中央医院内科某科出院患者进行评估;那些死亡或转移到另一个单位的人被排除在外。从临床记录中收集了有关性别,年龄,入院和出院治疗的数据以及可以支持PPI使用的诊断。使用Microsoft Excel 2013进行统计分析?和IBM SPSS Statistics 20?。结果:共收治318例住院病人,共301例。女性为171位(56.8%),平均年龄为75.4±14.6岁。在318例住院治疗中,入院时接受PPI的患者为148名(46.5%),出院时接受175例(55%)的患者,其中大多数患者没有适应症(n = 91,61.5%,n = 109,62.3%)。最主要的不适指征是单独抗凝治疗(n = 33,36.3%vs. n = 43,39.4%)。入院时有93例(29.2%)出院时有PPI疗法的指征,出院时有111例(34.9%)的指征,主要是为了预防高危患者的胃肠道出血(n = 82,88.2%vs. n = 96, 86.5%)。在那些有适应症的患者中,入院时有57(61.3%)人服药,出院时有66(59%)人。出院时,PPI治疗与其处方指示之间的关联已消失(p = 0.245)。结论:PPI处方与现有建议不一致,这就是为什么应该在出院时对其进行修订的原因。 PPI治疗的主要适应症是对高危患者的胃肠道出血的预防,而主要不适当的适应症是对低危患者的预防。指示使用PPI的大部分患者无需处方即可出院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号